Pluristem Therapeutics Inc.
PSTI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $89,956 | $63,370 | $65,636 | $5,553 |
| - Cash | $4,259 | $5,895 | $0 | $0 |
| + Debt | $6,702 | $6,761 | $6,239 | $5,498 |
| Enterprise Value | $92,399 | $64,236 | $71,875 | $11,051 |
| Revenue | $316 | $490 | $427 | $185 |
| % Growth | -35.5% | 14.8% | 130.8% | – |
| Gross Profit | $115 | $173 | $136 | $111 |
| % Margin | 36.4% | 35.3% | 31.9% | 60% |
| EBITDA | -$5,773 | -$10,512 | -$5,592 | -$5,202 |
| % Margin | -1,826.9% | -2,145.3% | -1,309.6% | -2,811.9% |
| Net Income | -$6,132 | $8,987 | -$6,335 | $1,847 |
| % Margin | -1,940.5% | 1,834.1% | -1,483.6% | 998.4% |
| EPS Diluted | -0.65 | -1.78 | -0.94 | -0.53 |
| % Growth | 63.5% | -89.4% | -77.4% | – |
| Operating Cash Flow | -$5,428 | $18,652 | -$4,303 | $730 |
| Capital Expenditures | -$116 | -$1,522 | -$577 | -$283 |
| Free Cash Flow | -$5,544 | $17,130 | -$4,880 | $447 |